Daily non-political popular news in brief.
Higher death rate for heart attack patients with additional non-cardiac conditions
11-10-2006 · EurekAlert!Heart attack patients who also have another acute condition such as stroke, kidney failure and pneumonia may have a poorer outcome than those without these conditions, and those with the most severe conditions account for a disproportionate percentage of hospital deaths, researchers at Yale School of Medicine report in a recent American Journal of Medicine.
Read more »
Keywords: higher, death, rate, heart, attack, patients, additional, non-cardiac, conditions, patient, non, cardiac, condition
« Previous | Next »
Similar news on "Higher death rate for heart attack patients with additional non-cardiac conditions":
- Ibuprofen puts high risk cardiac patients at risk
04-05-2007 · EurekAlert!
Doctors who treat the painful condition of osteoarthritis in patients with increased cardiovascular risk need to be cautious. A team lead by researchers at Mount Sinai School of Medicine, are the first to study outcomes in high cardiovascular risk patients with osteoarthritis. They have found that high cardiovascular risk patients taking ibuprofen and aspirin combined are nine times more likely suffer a heart attack.
Similar news · Read more »
- Analysis: Condition could predict life or death in heart patients
10-23-2006 · EurekAlert!
A growing health problem affecting older Americans puts them at higher risk for dying after heart surgery and other interventional procedures, such as heart catheterizations, according to findings published in the current edition of the Journal of the American College of Cardiology and co-authored by two leading University of Kentucky cardiologists.
Similar news · Read more »
- Common drug-releasing coronary stents appear to have similar clinical outcomes
01-29-2008 · EurekAlert!
A comparison of use of the first two commercially available drug-releasing coronary stents (for the medications sirolimus and paclitaxel) among patients in "everyday clinical practice" indicates no significant differences for outcomes such as heart attack or cardiac death, according to a study in the Jan. 30 issue of JAMA.
Similar news · Read more »
- Treating depression may improve recovery of heart rate variability following coronary syndromes
09-03-2007 · EurekAlert!
Patients with depression appear to have an impaired ability to recover their heart rate variability following acute coronary syndromes such as heart attack, a factor that could increase their risk of coronary death, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals. However, patients who are treated with antidepressants or whose mood lifts may experience more of an improvement in heart rate variability than those who are untreated or remain depressed.
Similar news · Read more »
- UMass Medical School study finds patients diagnosed with coronary heart disease continue poor diets
01-30-2008 · EurekAlert!
More than 13 million Americans have survived a heart attack or have been diagnosed with coronary heart disease, the number one cause of death in the United States. In addition to medications, lifestyle changes, such as a healthy diet and exercise, are known to reduce the risk for subsequent cardiac events. Despite this evidence, a high proportion of heart attack survivors do not follow their doctor's advice to adhere to a healthy diet.
Similar news · Read more »
- Drug does not reduce risk of death for heart attack patients with refractory shock
03-26-2007 · EurekAlert!
The medication tilarginine, a drug that was believed could be beneficial for patients who develop cardiogenic shock (low blood pressure due to impaired cardiac function) after a heart attack, did not reduce the risk of death up to six months after a heart attack, according to a JAMA study published online March 26. The study is being released early to coincide with its presentation at the American College of Cardiology's annual conference.
Similar news · Read more »
- Anti-anginal drug safe but not effective in reducing major cardiac events in ACS patients
04-24-2007 · EurekAlert!
The anti-anginal medication ranolazine was shown to be safe in regard to certain outcomes but did not reduce the risk of major cardiovascular events such as death, heart attack or recurrent ischemia following acute coronary syndromes, according to a study in the April 25 issue of JAMA.
Similar news · Read more »
- Due to cost, heart attack patients often avoid follow-up care and medication
03-13-2007 · EurekAlert!
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine. Published in the March 14 issue of Journal of the American Medical Association (JAMA), the study sought to determine if self-reported financial barriers to health care services or medication were associated with worse patient outcomes.
Similar news · Read more »
- Blood test predicts cardiac events and death in heart patients
01-09-2007 · EurekAlert!
A simple blood test for the protein NT-proBNP accurately predicts the risk of heart attack, heart failure, stroke and death in patients with known cardiovascular disease, according to a study led by a researcher at the San Francisco VA Medical Center.
Similar news · Read more »
- Stanford analysis shows little difference in risk rates for angioplasty, bypass procedures
10-15-2007 · EurekAlert!
Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers. The researchers also found that the survival rates for bypass surgery and angioplasty were similar for patients with diabetes, refuting previous reports that angioplasty was associated with a significantly higher risk of death among diabetic patients.
Similar news · Read more »
